ArticleFrontiers in psychiatry2025
A network analysis of facial and vocal emotion recognition deficits in schizophrenia.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Facial and vocal emotion recognition deficits are common in individuals with schizophrenia. Methods: In this observational, single-center study, 106 patients with schizophrenia (SCZ) and 118 age- and sex-matched healthy controls underwent cognitive and emotional function assessments. The Temporal Experience of Pleasure Scale (TEPS), Personal and Social Performance Scale, Positive and Negative Symptom Scale, and Brief Negative Symptom Scale were used to evaluate psychotic symptoms in the SCZ group. Participants were assessed using the MATRICS Consensus Cognitive Battery (MCCB), the Positive and Negative Syndrome Scale, and emotion recognition tests involving 42 facial and 42 vocal emotional tasks. Results: The SCZ group had significant impairments in facial and vocal emotion recognition, with lower accuracy across all emotional categories. Mean scores in the SCZ group were significantly lower than those in the control group (facial, 23.55 ± 7.10 vs. 31.86 ± 5.16; vocal, 18.64 ± 9.48 vs. 29.42 ± 5.01, respectively; p<0.001). Emotion recognition deficits and demographic or clinical characteristics were not significantly correlated. Network analysis revealed strong intercorrelations among different cognitive domains, linking MCCB performance to emotion recognition abilities (r>0.9; p<0.001). Integration of tests of cognitive function (MCCB, area under the curve [AUC]=91.90%, p<0.01), emotion recognition abilities (facial, AUC=82.56%; vocal, AUC=82.82%; p<0.01), and TEPS (AUC=91.13%, p<0.01) proved useful for distinguishing patients with schizophrenia from healthy individuals. Discussion: These findings underscore the importance of emotion recognition impairments in schizophrenia and their strong association with cognitive deficits. Future interventions should focus on targeted cognitive and affective training strategies. Incorporating multimodal assessments into clinical evaluations may enhance diagnostic accuracy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.